| Primary information |
|---|
| ID | 11765 |
| Uniprot ID | P10997 |
| Description | Islet amyloid polypeptide (Amylin) (Diabetes-associated peptide) (DAP) (Insulinoma amyloid peptide) |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the calcitonin family. |
| Tissue Specificity | NA |
| Post Translational Modification | Amyloid fibrils are degraded by IDE. |
| Function | Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle; while not affecting adipocyte glucose metabolism. |
| Length | 89 |
| Molecular Weight | 9 |
| Name | Islet amyloid polypeptide (Amylin) (Diabetes-associated peptide) (DAP) (Insulinoma amyloid peptide) |
| Sequence | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY |
| Sequence map | 37 |
| PDB ID | 1KUW; 2G48; 2KB8; 2L86; 3DG1; 3FPO; 3FR1; 3FTH; 3FTK; 3FTL; 3FTR; 3G7V; 3G7W; 3HGZ; 5K5G; 5KNZ; 5KO0 |
| Drugpedia | DB09130; |
| Receptor | P30988 |
| Domain | The mature protein is largely unstructured in the |
| Pharmaceutical Use | NA
|